Paraneoplastic syndrome: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
==Classification== | ==Classification== | ||
* Paraneoplastic syndromes may be [[Classification|classified]] into 4 main categories: | * Paraneoplastic syndromes may be [[Classification|classified]] into 4 main categories: | ||
**[[Endocrine|Endocrine metabolic]] [[Syndrome|syndromes]]: | **[[Endocrine|Endocrine metabolic]] [[Syndrome|syndromes]]: | ||
***[[Hypercalcemia]] in [[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]]) | ***[[Hypercalcemia]] in [[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]]) | ||
****Seen also in [[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]] | ****Seen also in [[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]] | ||
***[[Syndrome of inappropriate antidiuretic hormone|SIADH]] | ***[[Syndrome of inappropriate antidiuretic hormone|SIADH]] | ||
****Associated [[Cancer|cancers]]: [[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]] | ****Associated [[Cancer|cancers]]: [[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]] | ||
***[[Ectopic]] [[ACTH]] [[secretion]] associated with [[Small cell lung cancer|small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]] and other [[Cancer|cancers]] | ***[[Ectopic]] [[ACTH]] [[secretion]] associated with [[Small cell lung cancer|small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]] and other [[Cancer|cancers]] | ||
***[[Tumor induced osteomalacia]] | ***[[Tumor induced osteomalacia]] | ||
***[[Hypoglycemia]] | ***[[Hypoglycemia]] | ||
****Associated [[Cancer|cancers]]: [[Gastrointestinal tract|GI]], [[mesothelioma]], [[lung]], and [[sarcomas]] | ****Associated [[Cancer|cancers]]: [[Gastrointestinal tract|GI]], [[mesothelioma]], [[lung]], and [[sarcomas]] | ||
**[[Mucocutaneous|Musculocutaneous]] paraneoplastic syndromes | **[[Mucocutaneous|Musculocutaneous]] paraneoplastic syndromes | ||
***[[Dermatomyositis]] (25-50% of adult patients have an underlying [[malignancy]]) | ***[[Dermatomyositis]] (25-50% of adult patients have an underlying [[malignancy]]) | ||
***[[Leser-Trelat sign|Leser-Trélat sign]], a sudden onset of many [[Pigmented lesions|pigmented]] [[skin]] lesions. | ***[[Leser-Trelat sign|Leser-Trélat sign]], a sudden onset of many [[Pigmented lesions|pigmented]] [[skin]] lesions. | ||
****Associated cancers: gastrointestinal adenocarcinomas (gastric, colon, rectal), breast cancer, and lymphoproliferative disorders/lymphoma, melanoma, and etc. | ****Associated cancers: gastrointestinal adenocarcinomas (gastric, colon, rectal), breast cancer, and lymphoproliferative disorders/lymphoma, melanoma, and etc. | ||
***[[Acanthosis nigricans]], seen in gastric adenocarcinoma, endometrial cancer, and etc. | ***[[Acanthosis nigricans]], seen in gastric adenocarcinoma, endometrial cancer, and etc. | ||
***[[Necrolytic migratory erythema]] which may be seen in pancreatic tumor. | ***[[Necrolytic migratory erythema]] which may be seen in pancreatic tumor. | ||
***[[Sweet's syndrome]], most commonly associated with acute myeloid leukemia or another hematologic malignancy. | ***[[Sweet's syndrome]], most commonly associated with acute myeloid leukemia or another hematologic malignancy. | ||
***[[Pyoderma gangrenosum]] is associated with Squamous cell carcinoma, cutaneous lymphoma. | ***[[Pyoderma gangrenosum]] is associated with Squamous cell carcinoma, cutaneous lymphoma. | ||
**[[Neurological]] paraneoplastic syndromes: | **[[Neurological]] paraneoplastic syndromes: | ||
***[[Paraneoplastic cerebellar degeneration]] associated with [[lung]], [[ovarian]], [[breast]], [[lymphatic]], and other cancers | ***[[Paraneoplastic cerebellar degeneration]] associated with [[lung]], [[ovarian]], [[breast]], [[lymphatic]], and other cancers | ||
***[[Encephalomyelitis]] ([[inflammation]] of the [[brain]] and [[spinal cord]]) | ***[[Encephalomyelitis]] ([[inflammation]] of the [[brain]] and [[spinal cord]]) | ||
Line 34: | Line 34: | ||
***[[Encephalitis|Brainstem encephalitis]] | ***[[Encephalitis|Brainstem encephalitis]] | ||
***[[Opsoclonus]] (involving eye movement) | ***[[Opsoclonus]] (involving eye movement) | ||
***[[Encephalitis]] triggered by a [[teratoma]] | ***[[Encephalitis]] triggered by a [[teratoma]] | ||
***[[Polymyositis]] | ***[[Polymyositis]] | ||
***[[Lambert-Eaton myasthenic syndrome]] ([[LEMS]]) in [[Small cell lung cancer|small-cell lung cancer]] | ***[[Lambert-Eaton myasthenic syndrome]] ([[LEMS]]) in [[Small cell lung cancer|small-cell lung cancer]] | ||
Line 40: | Line 40: | ||
***Subacute (peripheral) [[sensory neuropathy]] | ***Subacute (peripheral) [[sensory neuropathy]] | ||
***[[Autonomic neuropathy]] | ***[[Autonomic neuropathy]] | ||
**[[Hematological]] paraneoplastic syndromes | **[[Hematological]] paraneoplastic syndromes | ||
***[[Granulocytosis]] (increased [[granulocyte]]s) due to the production of [[Granulocyte colony-stimulating factor|G-CSF]] | ***[[Granulocytosis]] (increased [[granulocyte]]s) due to the production of [[Granulocyte colony-stimulating factor|G-CSF]] | ||
*** [[Eosinophilia]] | *** [[Eosinophilia]] | ||
Line 49: | Line 49: | ||
==Causes== | ==Causes== | ||
===Common Causes=== | ===Common Causes=== | ||
* The major [[causes]] of paraneoplastic syndrome include: | * The major [[causes]] of paraneoplastic syndrome include: | ||
**[[Small cell lung cancer]] | **[[Small cell lung cancer]] | ||
** [[Non-small cell lung cancer]] | ** [[Non-small cell lung cancer]] | ||
Line 66: | Line 66: | ||
** [[Renal carcinoma]] | ** [[Renal carcinoma]] | ||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
*Paraneoplastic syndromes [[causes]] may be regrouped by organ system. | *Paraneoplastic syndromes [[causes]] may be regrouped by organ system. | ||
{| style="width:82%; height:100px" border="1" | {| style="width:82%; height:100px" border="1" | ||
|- | |- | ||
Line 249: | Line 249: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Cough]] | * [[Cough]] | ||
Line 284: | Line 284: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Asymptomatic]] at first | * [[Asymptomatic]] at first | ||
Line 322: | Line 322: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Asymptomatic]] at first | * [[Asymptomatic]] at first | ||
Line 376: | Line 376: | ||
!Additional findings | !Additional findings | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Lump]] in the [[breast]] | * [[Lump]] in the [[breast]] | ||
Line 409: | Line 409: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Hematuria]] | * [[Hematuria]] | ||
Line 451: | Line 451: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Epigastric]] [[pain]] | * [[Epigastric]] [[pain]] | ||
Line 495: | Line 495: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* History of [[gastric ulcer]] | * History of [[gastric ulcer]] | ||
Line 541: | Line 541: | ||
* [[Acanthosis nigricans]] | * [[Acanthosis nigricans]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Weight loss]] | * [[Weight loss]] | ||
Line 570: | Line 570: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Asymptomatic]] at first | * [[Asymptomatic]] at first | ||
Line 601: | Line 601: | ||
* [[Psammoma body|Psammoma bodies]] | * [[Psammoma body|Psammoma bodies]] | ||
* [[Necrosis]] | * [[Necrosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Biopsy]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Trousseau's syndrome|Trousseau]] [[syndrome]] | * [[Trousseau's syndrome|Trousseau]] [[syndrome]] | ||
Line 611: | Line 612: | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
<references /> |
Revision as of 19:15, 11 October 2019
PCFor patient information, click here
Paraneoplastic syndrome Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]
Synonyms and keywords: Paraneoplastic syndrome
Overview
Paraneoplastic syndromes are a rare type of disease that is caused by abnormal immune systems resulting from cancerous cells. Paraneoplastic syndromes are disorders due to the release of hormones, or peptides that cause immune cross-reactivity between cancerous cells and normal tissues. Sometimes the symptoms of paraneoplastic syndromes show even before the diagnosis of a malignancy. There is no screening for paraneoplastic syndromes. The stage and type of diagnosis of cancer determine the prognosis of a paraneoplastic syndrome. The causes are mostly related to the organ affected. The paraneoplastic syndromes are divided into four main categories such as musculocutaneous, neurological, hematological and endocrines. They are no cures for the paraneoplastic syndrome, but cancer treatment and some medications to reduce autoimmune responses are helpful.
Classification
- Paraneoplastic syndromes may be classified into 4 main categories:
- Endocrine metabolic syndromes:
- Hypercalcemia in breast cancer and lung cancer (typically squamous cell) due to the production of PTHrP (Parathyroid hormone-related protein)
- Seen also in multiple myeloma, renal cell carcinoma, ovarian cancer, endometrial cancer, and lymphoma
- SIADH
- Associated cancers: small cell lung cancer, mesothelioma, breast, prostate, adrenal, urethral, thymoma, lymphoma, GI, CNS, and Ewing sarcoma
- Ectopic ACTH secretion associated with small-cell lung cancer, carcinoid tumor, thymoma and other cancers
- Tumor induced osteomalacia
- Hypoglycemia
- Associated cancers: GI, mesothelioma, lung, and sarcomas
- Hypercalcemia in breast cancer and lung cancer (typically squamous cell) due to the production of PTHrP (Parathyroid hormone-related protein)
- Musculocutaneous paraneoplastic syndromes
- Dermatomyositis (25-50% of adult patients have an underlying malignancy)
- Leser-Trélat sign, a sudden onset of many pigmented skin lesions.
- Associated cancers: gastrointestinal adenocarcinomas (gastric, colon, rectal), breast cancer, and lymphoproliferative disorders/lymphoma, melanoma, and etc.
- Acanthosis nigricans, seen in gastric adenocarcinoma, endometrial cancer, and etc.
- Necrolytic migratory erythema which may be seen in pancreatic tumor.
- Sweet's syndrome, most commonly associated with acute myeloid leukemia or another hematologic malignancy.
- Pyoderma gangrenosum is associated with Squamous cell carcinoma, cutaneous lymphoma.
- Neurological paraneoplastic syndromes:
- Paraneoplastic cerebellar degeneration associated with lung, ovarian, breast, lymphatic, and other cancers
- Encephalomyelitis (inflammation of the brain and spinal cord)
- Limbic encephalitis
- Brainstem encephalitis
- Opsoclonus (involving eye movement)
- Encephalitis triggered by a teratoma
- Polymyositis
- Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer
- Myasthenia gravis
- Subacute (peripheral) sensory neuropathy
- Autonomic neuropathy
- Hematological paraneoplastic syndromes
- Granulocytosis (increased granulocytes) due to the production of G-CSF
- Eosinophilia
- Pure red cell aplasia
- Thrombocytosis
- Others:
- Endocrine metabolic syndromes:
Causes
Common Causes
- The major causes of paraneoplastic syndrome include:
Causes by Organ System
- Paraneoplastic syndromes causes may be regrouped by organ system.
Dermatologic | |
Ear Nose Throat | |
Endocrine | |
Gastroenterologic |
|
Hematologic | |
Musculoskeletal/Orthopedic | |
Neurologic | |
Obstetric/Gynecologic | |
Oncologic | |
Pulmonary | |
Renal/Electrolyte | |
Rheumatology/Immunology/Allergy |
|
Urologic | |
Miscellaneous |
Differential diagnosis
Paraneoplastic syndromes must be differentiated from others types of cancer depending on the location and type of organs.
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Small cell lung cancer |
|
_ |
|
_ | Small, round and oval cells | Biopsy | _ | ||||||||
Squamous lung cancer |
|
|
|
|
_ | _ |
|
_ |
|
_ | |||||
Hepatocellular carcinoma |
|
_ | _ | _ |
|
|
_ | ||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Breast cancer |
|
|
|
|
_ | _ | _ | _ | _ |
|
_ | ||||
Renal cancer |
|
|
|
_ | _ |
|
_ | ||||||||
Pancreatic cancer |
|
|
_ |
|
_ | ||||||||||
Gastric cancer |
|
_ |
|
_ |
|
_ |
|
| |||||||
Lymphoma | _ |
|
|
_ | _ | _ |
|
_ | |||||||
Ovarian cancer |
|
|
|
|
_ | _ |
|